Clinical Problems with Developmental Anomalies of the Biliary Tract

Seminars in Gastrointestinal Disease

Volumn 14, Issue 4, 2003, Pages 156-164

  Suchy, Frederick J ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RIFAMPICIN;

ALAGILLE SYNDROME; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; AUTOSOMAL DOMINANT DISORDER; BILE DUCT; BILE DUCT ATRESIA; BILE DUCT OBSTRUCTION; BILIARY TRACT DISEASE; CASE REPORT; CHOLESTASIS; COMMON BILE DUCT CYST; CONGENITAL INFECTION; DIET SUPPLEMENTATION; FEMALE; HUMAN; HYPERBILIRUBINEMIA; INBORN ERROR OF METABOLISM; INFANT; LAPAROTOMY; LIVER BIOPSY; LIVER CELL; LIVER DISEASE; LIVER DYSFUNCTION; MALE; NUTRITIONAL SUPPORT; OBSTRUCTIVE JAUNDICE; PORTOENTEROSTOMY; PROGNOSIS; PRURITUS;

EID: 0346333020     PISSN: 10495118     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (59)

1. Yerushalmi B, Sokol RJ, Narkewicz MR, et al: Use of rifampin for severe pruritus in children with chronic cholestasis. J Pediatr Gastroenterol Nutr 29:442-447, 1999
2. Bezerra JA, Balistreri WF. Cholestatic syndromes of infancy and childhood. Semin Gastrointest Dis 12:1254-1265, 2001
3. McKiernan PJ: Neonatal cholestasis. Semin Neonatol 7:153-165, 2002
4. Mieli-Vergani G, Howard ER, Portman B, et al: Late referral for biliary atresia - Missed opportunities for effective surgery. Lancet 1:421-423, 1989
5. Desmet VJ: Vanishing bile duct disorders. Prog Liver Dis 10:89-121, 1992
6. McEvoy CF, Suchy FJ: Biliary tract disease in children. Pediatr Clin North Am 43:75-98, 1996
7. Hadchouel M: Paucity of interlobular bile ducts. Semin Diagn Pathol 9:24-30, 1992
8. Birnbaum A, Suchy FJ: The intrahepatic cholangiopathies. Semin Liver Dis 18:263-269, 1998
9. Kahn E: Paucity of interlobular bile ducts. Arteriohepatic dysplasia and nonsyndromic duct paucity. Perspect Pediatr Pathol 14:168-215, 1991
10. Tirona RG, Leake BF, Wolkoff AW, et al: Human organic anion transporting polypeptide-C (SLC21A6) is a major determinant of rifampin-mediated pregnane X receptor activation. J Pharmacol Exp Ther 304:223-228, 2003
11. Bates MD, Bucuvalas JC, Alonso MH, et al: Biliary atresia: Pathogenesis and treatment. Semin Liver Dis 18:281-293, 1998
12. Nio M, Ohi R: Biliary atresia. Semin Pediatr Surg 9:177-186, 2000
13. Tan Kendrick AP, Phua KB, Ooi BC, et al: Making the diagnosis of biliary atresia using the triangular cord sign and gallbladder length. Pediatr Radiol 30:69-73, 2000
14. Kotb MA, Kotb A, Sheba MF, et al: Evaluation of the triangular cord sign in the diagnosis of biliary atresia. Pediatrics 108:416-420, 2001
15. Tan Kendrick AP, Phua KB, Ooi BC, et al: Biliary atresia: Making the diagnosis by the gallbladder ghost triad. Pediatr Radiol 33:311-315, 2003
16. Gilmour SM, Hershkop M, Reifen R, et al: Outcome of hepatobiliary scanning in neonatal hepatitis syndrome. J Nucl Med 38:1279-1282, 1997
17. Zerbini MC, Gallucci SD, Maezono R, et al: Liver biopsy in neonatal cholestasis: A review on statistical grounds. Mod Pathol 10:793-799, 1997
18. Low Y, Vijayan V, Tan CE: The prognostic value of ductal plate malformation and other histologic parameters in biliary atresia: An immunohistochemical study. J Pediatr 139:320-322, 2001
19. Lefkowitch JH: Biliary atresia. Mayo Clin Proc 73:90-95, 1998
20. Yoon PW, Bresee JS, Olney RS, et al: Epidemiology of biliary atresia: a population-based study. Pediatrics 99:376-382, 1997
21. Chardot C, Carton M, Spire-Bendelac N, et al: Epidemiology of biliary atresia in France: A national study 1986-96. J Hepatol 31:1006-13, 1999
22. Tyler KL, Sokol RJ, Oberhaus SM, et al: Detection of reovirus RNA in hepatobiliary tissues from patients with extrahepatic biliary atresia and choledochal cysts. Hepatology 27:1475-1482, 1998
23. Bezerra JA, Tiao G, Ryckman FC, et al: Genetic induction of proinflammatory immunity in children with biliary atresia. Lancet 360:1653-1659, 2002
24. Broome U, Nemeth A, Hultcrantz R, et al: Different expression of HLA-DR and ICAM-1 in livers from patients with biliary atresia and Byler's disease. J Hepatol 26:857-862, 1997
25. Carmi R, Magee CA, Neill CA, et al: Extrahepatic biliary atresia and associated anomalies: etiologic heterogeneity suggested by distinctive patterns of associations. Am J Med Genet 45:683-693, 1993
26. Mazziotti MV, Willis LK, Heuckeroth RO, et al: Anomalous development of the hepatobiliary system in the Inv mouse. Hepatology 30:372-378, 1999
27. Bamford RN, Roessler E, Burdine RD, et al: Loss-of-function mutations in the EGF-CFC gene CFC1 are associated with human left-right laterality defects. Nat Genet 26:365-369, 2000
28. Ohi R: Surgery for biliary atresia. Liver 21:175-182, 2001
29. Howard ER, Davenport M: The treatment of biliary atresia in Europe 1969-1995. Tohoku J Exp Med 181:5-83, 1997
30. Petersen C, Ure BM: What's new in biliary atresia? Eur J Pediatr Surg 13:1-6, 2003
31. Dillon PW, Owings E, Cilley R, et al: Immunosuppression as adjuvant therapy for biliary atresia. J Pediatr Surg 36:80-85, 2001
32. Meyers RL, Book LS, O'Gorman MA, et al: High-dose steroids, ursodeoxycholic acid, and chronic intravenous antibiotics improve bile flow after Kasai procedure in infants with biliary atresia. J Pediatr Surrg 38:406-411, 2003
33. Bu LN, Chen HL, Chang CJ, et al: Prophylactic oral antibiotics in prevention of recurrent cholangitis after the Kasai portoenterostomy. J Pediatr Surg 38:590-593, 2003
34. McKiernan PJ, Baker AJ, Kelly DA: The frequency and outcome of biliary atresia in the UK and Ireland. Lancet 355:25-29, 2000
35. Renz JF, de Roos M, Rosenthal P, et al: Posttransplantation growth in pediatric liver recipients. Liver Transplant 7:1040-1055, 2001
36. Gridelli B, Spada M, Petz W, et al: Split-liver transplantation eliminates the need for living-donor liver transplantation in children with end-stage cholestatic liver disease. Transplantation 75:1197-1203, 2003
37. Chardot C, Carton M, Spire-Bendelac N, et al: Prognosis of biliary atresia in the era of liver transplantation: French national study from 1986 to 1996. Hepatology 30:606-611, 1999
38. Ryckman FC, Alonso MH, Bucuvalasn JC, et al: Biliary atresia-Surgical management and treatment options as they relate to outcome. Liver Transplant Surg 4(suppl): S24-33, 1998
39. Lang T, Kappler M, Dietz H, et al: Biliary atresia: Which factors predict the success of a Kasai operation? An analysis of 36 patients. Eur J Med Res 5:110-114, 2000
40. Wu ET, Chen HL, Ni YH, et al: Bacterial cholangitis in patients with biliary atresia: impact on short-term outcome. Pediatr Surg Int 17:390-395, 2001
41. Ernest Van Heurn LW, Saing H, Tam PK: Cholangitis after hepatic portoenterostomy for biliary atresia: A multivariate analysis of risk factors. J Pediatr 142:566-571, 2003
42. Alagille D, Estrada A, Hadchouel M, et al: Syndromic paucity of interlobular bile ducts (Alagille syndrome or arteriohepatic dysplasia): Review of 80 cases. J Pediatr 110:195-200, 1987
43. Piccoli DA, Spinner NB: Alagille syndrome and the Jagged1 gene. Semin Liver Dis 21:525-534, 2001
44. Kamath BM, Loomes KM, Oakey RJ, et al: Facial Features in Alagille syndrome: Specific or cholestasis facies? Am J Med Genet 112:163-170, 2002
45. Krantz ID, Piccoli DA, Spinner NB: Alagille syndrome. J Med Genet 34:152-157, 1997
46. Emerick KM, Rand EB, Goldmuntz E, et al: Features of' Alagille syndrome in 92 patients: frequency and relation to prognosis. Hepatology 29:822-829, 1999
47. Deutsch GH, Sokol RJ, Stathos TH, et al: Proliferation to paucity: evolution of bile duct abnormalities in a case of Alagille syndrome. Pediatr Dev Pathol 4:559-563, 2001
48. Oda T, Elkahloun AG, Pike BL, et al: Mutations in the human Jagged1 gene are responsible for Alagille syndrome. Nat Genet 16:235-242[see comments], 1997
49. Spinner NB: Alagille syndrome and the notch signaling pathway: New insights into human development. Gastroenterology 116:1257-1260[editorial; comment], 1999
50. Gridley T: Notch signaling and inherited disease syndromes. Hum Mol Genet 12:R9-R13, 2003 (suppl)
51. Jones EA, Clement-Jones M, Wilson DI: JAGGED1 expression in human embryos: Correlation with the Alagille syndrome phenotype. J Med Genet 37:663-668, 2000
52. Louis AA, Van Eyken P, Haber BA, et al: Hepatic jagged1 expression studies. Hepatology 30:1269-1275, 1999
53. Crosnier C, Attie-Bitach T, Encha-Razavi F, et al: JAGGED1 gene expression during human embryogenesis elucidates the wide phenotypic spectrum of Alagille syndrome. Hepatology 32:574-581, 2000
54. Spinner NB, Colliton RP, Crosnier C, et al: Jagged1 mutations in Alagille syndrome. Hum Mutat 17:18-33, 2001
55. Bucuvalas JC, Horn JA, Carlsson L, et al: Growth hormone insensitivity associated with elevated circulating growth hormone-binding protein in children with Alagille syndrome and short stature. J Clin Endocrinol Metab 76:1477-1482, 1993
56. Rovner AJ, Schall JI, Jawad AF, et al: Rethinking growth failure in Alagille syndrome: the role of dietary intake and steatorrhea. J Pediatr Gastroenterol Nutr 35:495-502, 2002
57. Emerick KM, Whitington PF: Partial external biliary diversion for intractable pruritus and xanthomas in Alagille syndrome. Hepatology 35:1501-1506, 2002
58. Lykavieris P, Hadchouel M, Chardot C, et al: Outcome of liver disease in children with Alagille syndrome: A study of 163 patients. Gut 49:431-435, 2001
59. Gurkan A, Emre S, Fishbein TM, et al: Unsuspected bile duct paucity in donors for living-related liver transplantation: Two case reports. Transplantation 67:416-418, 1999